| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $313.3M | -5.9% | +9.3% |
| Cost of Revenue | $240.5M | -5.3% | +5.8% |
| Gross Profit | $72.8M | -7.8% | +22.9% |
| R&D Expense | $2.6M | +13.0% | — |
| SG&A Expense | $33.4M | -7.8% | +10.0% |
| Operating Income | $21.5M | -11.6% | +72.8% |
| Pre-tax Income | $24.0M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $134.0M | +1.1% | +46.5% |
| Accounts Receivable | $252.5M | -7.1% | -10.1% |
| Current Assets | $622.0M | +4.6% | +13.9% |
| Total Assets | $795.2M | +4.5% | +20.5% |
| Current Liabilities | $210.5M | -4.5% | +1.0% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $156.0M | — | — |
| Capital Expenditures | $12.8M | — | — |
| Investing Cash Flow | -$167.3M | — | — |
| Financing Cash Flow | -$11.1M | — | — |
| Free Cash Flow | $143.2M | — | — |
| -11.5% |
| +33.4% |
| Income Tax | $10.1M | +1.4% | +33.9% |
| Net Income | $13.9M | -19.0% | +33.0% |
| EPS (Basic) | $0.16 | -20.0% | +33.3% |
| EPS (Diluted) | $0.15 | -21.1% | +36.4% |
| $235.2M |
| -4.4% |
| +4.5% |
| Stockholders' Equity | $560.0M | +8.7% | +28.8% |